Sun Pharmaceutical Industries Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 1,08,785.22 | 92,100.58 | 85,499.65 | 80,743.59 |
| Cash Equivalents | 11,603.08 | 8,014.67 | 8,062.95 | 1,387.17 |
| Other Liabilities Total | 1,499.64 | 860.96 | 914.46 | 930.14 |
| Long Term Debt | 31.26 | 2.52 | 1.33 | 0.00 |
| Common Stock Total | 239.93 | 239.93 | 239.93 | 239.93 |
| Other Current Assets Total | 2,864.77 | 1,465.98 | 355.46 | 414.35 |
| Total Assets | 1,08,785.22 | 92,100.58 | 85,499.65 | 80,743.59 |
| Current Portof LT Debt/ Capital Leases | 4,234.43 | 151.27 | 125.69 | 367.70 |
| Total Equity | 83,570.09 | 72,218.02 | 63,666.75 | 55,995.38 |
| Long Term Investments | 3,855.68 | 4,758.15 | 6,501.58 | 5,457.48 |
| Retained Earnings( Accumulated Deficit) | 83,330.16 | 61,825.79 | 54,118.50 | 47,574.20 |
| Total Common Shares Outstanding | 239.93 | 239.93 | 239.93 | 239.93 |
| Tangible Book Valueper Share Common Eq | 250.86 | 226.14 | 193.24 | 158.19 |
| Goodwill Net | 9,833.08 | 8,939.42 | 8,568.99 | 8,712.71 |
| Total Liabilities | 25,215.13 | 19,882.56 | 21,832.90 | 24,748.21 |
| Total Debt | 4,627.32 | 2,362.19 | 3,273.67 | 6,885.87 |
| Short Term Investments | 22,337.14 | 13,721.34 | 8,608.00 | 9,390.34 |
| Cashand Short Term Investments | 33,940.22 | 25,032.96 | 19,113.52 | 15,147.74 |
| Total Receivables Net | 15,562.37 | 14,960.80 | 13,255.70 | 12,959.76 |
| Deferred Income Tax | 390.91 | 201.20 | 171.86 | 31.69 |
| Accounts Receivable- Trade Net | 15,509.67 | 13,122.51 | 11,302.97 | 11,489.29 |
| Property/ Plant/ Equipment Total- Net | 12,494.76 | 11,270.28 | 11,300.05 | 11,353.73 |
| Minority Interest | 309.65 | 267.93 | 3,459.19 | 3,320.09 |
| Total Current Liabilities | 22,622.04 | 18,194.21 | 16,983.77 | 19,906.38 |
| Total Inventory | 11,492.93 | 10,759.33 | 10,294.89 | 10,968.32 |
| Accounts Payable | 7,333.80 | 6,184.34 | 5,653.30 | 5,681.52 |
| Other Currentliabilities Total | 11,053.81 | 8,120.36 | 6,671.51 | 6,386.17 |
| Total Long Term Debt | 392.89 | 358.26 | 303.62 | 559.91 |
| Intangibles Net | 13,546.16 | 9,020.54 | 8,732.99 | 9,326.84 |
| Other Long Term Assets Total | 4,548.36 | 4,878.20 | 4,488.27 | 3,582.08 |
| Note Receivable- Long Term | 646.89 | 639.93 | 2,474.66 | 2,448.81 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 63,860.29 | 52,594.06 | 43,433.11 | 39,861.94 |
| Capital Lease Obligations | 361.63 | 355.74 | 302.29 | 559.91 |
| Accumulated Depreciation Total | - | -13,574.78 | -12,576.04 | -11,622.63 |
| Accrued Expenses | - | 1,885.58 | 1,688.91 | 1,512.73 |
| Other Equity Total | - | 7,989.43 | 7,096.43 | 6,778.88 |
| Prepaid Expenses | - | 374.99 | 413.54 | 371.77 |
| Additional Paid- In Capital | - | 1,187.41 | 1,187.41 | 1,187.41 |
| Cash | - | 3,296.95 | 2,442.57 | 4,370.23 |
| Property/ Plant/ Equipment Total- Gross | - | 23,610.72 | 22,768.36 | 22,013.01 |
| Notes Payable/ Short Term Debt | - | 1,852.66 | 2,844.36 | 5,958.26 |
| Unrealized Gain( Loss) | - | 975.46 | 1,024.48 | 214.96 |
Sun Pharmaceutical Industries Quick Links
Sun Pharmaceutical Industries Dividend Sun Pharmaceutical Industries Bonus Sun Pharmaceutical Industries News Sun Pharmaceutical Industries AGM Sun Pharmaceutical Industries Rights Sun Pharmaceutical Industries Splits Sun Pharmaceutical Industries Board Meetings Sun Pharmaceutical Industries Key Metrics Sun Pharmaceutical Industries Shareholdings Sun Pharmaceutical Industries Profit Loss Sun Pharmaceutical Industries Cashflow Sun Pharmaceutical Industries Q1 Results Sun Pharmaceutical Industries Q2 Results Sun Pharmaceutical Industries Q3 Results Sun Pharmaceutical Industries Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.